Clinical Trials on Macrophage Activation Syndrome in United States
Total 14268 results
-
Opsona Therapeutics Ltd.M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaboratorsCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
Rush University Medical CenterH. Lundbeck A/STerminatedMyelodysplastic SyndromeUnited States
-
Arno TherapeuticsUnknown
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterCompletedMyelodysplastic SyndromeUnited States
-
Veeda OncologyCephalonTerminatedMyelodysplastic SyndromeUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndromes | Hematologic DiseasesUnited States
-
AllerganCompletedDry Eye SyndromesUnited States
-
National Cancer Institute (NCI)RecruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruiting
-
Gustavo RiveroBaylor College of MedicineTerminatedMyelodysplastic SyndromesUnited States
-
University of CincinnatiGenentech, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminatedMyelodysplastic SyndromeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCTI BioPharmaCompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
University of FloridaTeva Pharmaceutical Industries, Ltd.WithdrawnMyelodysplastic SyndromesUnited States
-
Virginia Commonwealth UniversityCelgene CorporationCompletedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelodysplastic SyndromesUnited States
-
University of PittsburghCompletedMyelodysplastic SyndromesUnited States
-
The Vaccine CompanyUnknownMyelodysplastic SyndromesUnited States
-
Texas Oncology Cancer CenterGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromesUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Aplastic Anemia | de Novo Myelodysplastic SyndromeUnited States
-
Thomas Jefferson UniversityWithdrawnMyelodysplastic SyndromesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Alliance for Cancer Gene TherapyTerminatedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.WithdrawniCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesUnited States
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Neal Young, M.D.CompletedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMyelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | IPSS Risk Category Intermediate-1United States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndrome | 5q Minus SyndromeUnited States
-
Uma BorateRecruitingTherapy-Related Myelodysplastic Syndrome | Secondary Myelodysplastic SyndromeUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); University of Illinois at Chicago; Aurora Health... and other collaboratorsCompletedSmoking | Smoking Cessation | Nicotine Dependence | MotivationUnited States
-
Franziska WachterHarvard Clinical and Translational Science Center (Harvard Catalyst)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | MDS | Aml | Myeloid Neoplasm | Myeloid Malignancies | Inherited Bone Marrow Failure SyndromeUnited States
-
Lindsey Russell, MDNapo Pharmaceuticals, Inc.Not yet recruitingShort Bowel SyndromeUnited States
-
ReGenTree, LLCCompletedAssessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2Dry Eye SyndromeUnited States
-
Boston Children's HospitalEntrinsic Bioscience Inc.TerminatedShort Bowel SyndromeUnited States
-
Le Bonheur Children's HospitalUniversity of Tennessee Health Science CenterUnknown
-
University of Colorado, DenverNo longer available
-
Children's Hospital Medical Center, CincinnatiApproved for marketingDravet SyndromeUnited States
-
J&M ShulerNonin Medical, IncCompletedAcute Compartment SyndromeUnited States